With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Drug Screen for FPD/AML Therapeutics||Children's Hospital of Philadelphia / Mortimer Poncz, MD||RARE Grant Program (Research Accelerating RUNX1 Exploration)||2017||Pennsylvania|
|Role of Inflammatory Microenvironment in Clonal evolution and Progression from FPD to AML||Oregon Health & Science University / Anupriya Agarwal, PhD||RARE Grant Program (Research Accelerating RUNX1 Exploration)||2017||Oregon|
|Pediatric Precision Oncology: Parent and Adolescent Experiences||Hospital for Sick Children / Anita Villani, MD||Psychosocial Launch Grant||2017||Ontario|
|A Home Physical Activity Program to Improve Cognitive Late Effects in Children Treated with Radiation for Brain Tumors||National Cancer Institute / Pamela Wolters, PhD||Psychosocial Family Impact Grant||2017||Maryland|
|Families of Children with Advanced Cancer: Quality of Life & Goals of Care||Research Institute at Nationwide Children's Hospital / Cindy Gerhardt, PhD||Psychosocial Family Impact Grant||2017||Ohio|
|Symptom Burden, Health-Related Quality of Life and Health Care Utilization Among Children Undergoing Hematopoietic Stem Cell Transplantation: Impact of Parent Sleep, Fatigue and Psychological Distress||Children's Hospital Los Angeles / Jessica Ward, PhD||Nurse Researcher Fellowship Grant||2017||California|
|Natural Killer T cells with an IL-15-armored GD2-specific CAR for Children with Neuroblastoma||Baylor College of Medicine / Andras Heczey, MD||Bio-Therapeutic Impact Award||2017||Texas|
|Phase I Study of Lentivirus Engineered Autologous AML Cells Expressing IL-12 in Children and Young Adults with Relapsed AML||Children's Hospital of Wisconsin - Milwaukee / Michael Burke, MD & Jeffrey Medin, MD/PhD||Reach Grants||2017||Wisconsin|
|Therapeutic Targeting of PGBD5-induced DNA Repair Dependency in Pediatric Solid Tumors||Memorial Sloan-Kettering Cancer Center / Alex Kentsis, MD/PhD||Reach Grants||2017||New York|
|Targeting Chondroitin Sulphate Proteoglycan 4 (CSPG4) in Glioblastoma||University of North Carolina / Gianpietro Dotti, MD & Barbara Savoldo, MD/PhD||Reach Grants||2017||North Carolina|